Progesterone promotes the acrosome reaction in capacitated human spermatozoa as judged by flow cytometry and CD46 staining.
The acrosome reaction is a necessary prerequisite for spermatozoa to acquire fertilizing ability. Several different moieties appear to promote the acrosome reaction through different pathways, including solubilized zona pellucidae, recombinant zona protein ZP3, follicular fluid, calcium ionophores, and mannosylated bovine serum albumin (BSA). Although many investigators have presented evidence that progesterone also promotes the acrosome reaction through the mediation of a non-genomic cell membrane receptor, this concept has been challenged. Other workers have suggested that progesterone does not promote an acrosome reaction in human spermatozoa, as judged by the detection of CD46, a complement regulatory protein present on the inner acrosome membrane, through flow cytometric analysis of large numbers of spermatozoa. Prior investigations were criticized by the limited numbers of spermatozoa enumerated visually, the use of non-specific staining techniques, and the failure to eliminate dead spermatozoa during the scoring of the acrosome reaction. We have repeated these experiments, using both a supravital dye to eliminate dead spermatozoa from flow cytometric analysis, and anti-CD46 monoclonal antibody to score acrosome-reacted spermatozoa. Care was taken to validate the adequacy of capacitation conditions, which were proven by the ability of spermatozoa to acrosome react in response to mannosylated BSA and to penetrate zona-free hamster eggs. Confocal microscopy was used to confirm that CD46 immunostaining was limited to the acrosomal region of the spermatozoon head. Our results indicate that progesterone does promote an acrosome reaction within capacitated spermatozoa.
Bronson
R A
RA
Department of Obstetrics & Gynecology, Health Sciences Center, State University of New York at Stony Brook, 11794-8091, USA.
Peresleni
T
T
Golightly
M
M
D020101:Acrosome Reaction / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D015703:Antigens, CD / Q000032:analysis / Q000378:metabolism*; D006690:Bisbenzimidazole / Q000737:chemistry; D016923:Cell Death; D006224:Cricetinae; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007248:Infertility, Male; D008297:Male; D008358:Mannose / Q000494:pharmacology; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000032:analysis / Q000378:metabolism*; D018613:Microscopy, Confocal; D011374:Progesterone / Q000494:pharmacology / Q000502:physiology*; D012709:Serum Albumin / Q000494:pharmacology; D013084:Sperm-Ovum Interactions; D013094:Spermatozoa / Q000187:drug effects / Q000502:physiology*; D013194:Staining and Labeling / Q000379:methods
D015703:Antigens, CD; C497857:CD46 protein, human; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D012709:Serum Albumin; C023840:mannose-bovine serum albumin conjugate; D011374:Progesterone; D006690:Bisbenzimidazole; D008358:Mannose